Cargando…

Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study

BACKGROUND: Glaucoma, the silent thief of sight, is a major cause of blindness worldwide. It is a burden for people in low-income countries, specifically countries where glaucoma-induced blindness accounts for 15% of the total incidence of blindness. More than half the people living with glaucoma in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nida, Esmael Kedir, Bekele, Sisay, Geurts, Luc, Vanden Abeele, Vero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486992/
https://www.ncbi.nlm.nih.gov/pubmed/34533462
http://dx.doi.org/10.2196/26602
_version_ 1784577861270634496
author Nida, Esmael Kedir
Bekele, Sisay
Geurts, Luc
Vanden Abeele, Vero
author_facet Nida, Esmael Kedir
Bekele, Sisay
Geurts, Luc
Vanden Abeele, Vero
author_sort Nida, Esmael Kedir
collection PubMed
description BACKGROUND: Glaucoma, the silent thief of sight, is a major cause of blindness worldwide. It is a burden for people in low-income countries, specifically countries where glaucoma-induced blindness accounts for 15% of the total incidence of blindness. More than half the people living with glaucoma in low-income countries are unaware of the disease until it progresses to an advanced stage, resulting in permanent visual impairment. OBJECTIVE: This study aims to evaluate the acceptability of the Glaucoma Easy Screener (GES), a low-cost and portable visual field screening platform comprising a smartphone, a stereoscopic virtual reality headset, and a gaming joystick. METHODS: A mixed methods study that included 24 eye care professionals from 4 hospitals in Southwest Ethiopia was conducted to evaluate the acceptability of GES. A pre-post design was used to collect perspectives before and after using the GES by using questionnaires and semistructured interviews. A Wilcoxon signed-rank test was used to determine the significance of any change in the scores of the questionnaire items (two-tailed, 95% CI; α=.05). The questionnaire and interview questions were guided by the Unified Theory of Acceptance and Use of Technology. RESULTS: Positive results were obtained both before and after use, suggesting the acceptance of mobile health solutions for conducting glaucoma screening by using a low-cost headset with a smartphone and a game controller. There was a significant increase (two-tailed, 95% CI; α=.05) in the average scores of 86% (19/22) of postuse questionnaire items compared with those of preuse questionnaire items. Ophthalmic professionals perceived GES as easy to use and as a tool that enabled the conduct of glaucoma screening tests, especially during outreach to rural areas. However, positive evaluations are contingent on the accuracy of the tool. Moreover, ophthalmologists voiced the need to limit the tool to screening only (ie, not for making diagnoses). CONCLUSIONS: This study supports the feasibility of using a mobile device in combination with a low-cost virtual reality headset and classic controller for glaucoma screening in rural areas. GES has the potential to reduce the burden of irreversible blindness caused by glaucoma. However, further assessment of its sensitivity and specificity is required.
format Online
Article
Text
id pubmed-8486992
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-84869922021-10-18 Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study Nida, Esmael Kedir Bekele, Sisay Geurts, Luc Vanden Abeele, Vero JMIR Form Res Original Paper BACKGROUND: Glaucoma, the silent thief of sight, is a major cause of blindness worldwide. It is a burden for people in low-income countries, specifically countries where glaucoma-induced blindness accounts for 15% of the total incidence of blindness. More than half the people living with glaucoma in low-income countries are unaware of the disease until it progresses to an advanced stage, resulting in permanent visual impairment. OBJECTIVE: This study aims to evaluate the acceptability of the Glaucoma Easy Screener (GES), a low-cost and portable visual field screening platform comprising a smartphone, a stereoscopic virtual reality headset, and a gaming joystick. METHODS: A mixed methods study that included 24 eye care professionals from 4 hospitals in Southwest Ethiopia was conducted to evaluate the acceptability of GES. A pre-post design was used to collect perspectives before and after using the GES by using questionnaires and semistructured interviews. A Wilcoxon signed-rank test was used to determine the significance of any change in the scores of the questionnaire items (two-tailed, 95% CI; α=.05). The questionnaire and interview questions were guided by the Unified Theory of Acceptance and Use of Technology. RESULTS: Positive results were obtained both before and after use, suggesting the acceptance of mobile health solutions for conducting glaucoma screening by using a low-cost headset with a smartphone and a game controller. There was a significant increase (two-tailed, 95% CI; α=.05) in the average scores of 86% (19/22) of postuse questionnaire items compared with those of preuse questionnaire items. Ophthalmic professionals perceived GES as easy to use and as a tool that enabled the conduct of glaucoma screening tests, especially during outreach to rural areas. However, positive evaluations are contingent on the accuracy of the tool. Moreover, ophthalmologists voiced the need to limit the tool to screening only (ie, not for making diagnoses). CONCLUSIONS: This study supports the feasibility of using a mobile device in combination with a low-cost virtual reality headset and classic controller for glaucoma screening in rural areas. GES has the potential to reduce the burden of irreversible blindness caused by glaucoma. However, further assessment of its sensitivity and specificity is required. JMIR Publications 2021-09-17 /pmc/articles/PMC8486992/ /pubmed/34533462 http://dx.doi.org/10.2196/26602 Text en ©Esmael Kedir Nida, Sisay Bekele, Luc Geurts, Vero Vanden Abeele. Originally published in JMIR Formative Research (https://formative.jmir.org), 17.09.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Nida, Esmael Kedir
Bekele, Sisay
Geurts, Luc
Vanden Abeele, Vero
Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study
title Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study
title_full Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study
title_fullStr Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study
title_full_unstemmed Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study
title_short Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study
title_sort acceptance of a smartphone-based visual field screening platform for glaucoma: pre-post study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486992/
https://www.ncbi.nlm.nih.gov/pubmed/34533462
http://dx.doi.org/10.2196/26602
work_keys_str_mv AT nidaesmaelkedir acceptanceofasmartphonebasedvisualfieldscreeningplatformforglaucomaprepoststudy
AT bekelesisay acceptanceofasmartphonebasedvisualfieldscreeningplatformforglaucomaprepoststudy
AT geurtsluc acceptanceofasmartphonebasedvisualfieldscreeningplatformforglaucomaprepoststudy
AT vandenabeelevero acceptanceofasmartphonebasedvisualfieldscreeningplatformforglaucomaprepoststudy